Adaptive Biotechnologies Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	295.41	276.98	178.96	170.28	185.31	154.34
Revenue Growth (YoY)	55.86%	54.77%	5.10%	-8.11%	20.06%	56.88%
Cost of Revenue	73.09	71.36	72.08	75.55	57.91	49.3
Gross Profit	222.32	205.62	106.88	94.72	127.4	105.04
Selling, General & Admin	174.16	167.27	157.57	172.51	184.13	169.97
Depreciation & Amortization Expenses	1.7	1.7	1.7	1.7	1.7	1.7
Research & Development	93.19	93.77	102.95	122.12	141.76	142.34
Other Operating Expenses	-	-	7.21	25.43	-	-
Total Operating Expenses	269.04	262.74	269.43	321.76	327.59	314.01
Operating Income	-46.73	-57.12	-162.55	-227.04	-200.19	-208.97
Interest Expense	-11.76	-11.78	-11.58	-13.8	-4.24	-
Other Non-Operating Income (Expense)	8.85	9.44	14.53	15.53	4.06	1.67
Total Non-Operating Income (Expense)	-2.92	-2.33	2.95	1.73	-0.18	1.67
Pretax Income	-49.64	-59.46	-159.6	-225.3	-200.37	-207.3
Net Income	-49.68	-59.5	-159.49	-225.25	-200.19	-207.28
Minority Interest in Earnings	0.04	0.04	-0.1	-0.05	-0.18	-0.02
Net Income to Common	-49.68	-59.5	-159.49	-225.25	-200.19	-207.28
Shares Outstanding (Basic)	153	152	147	144	143	140
Shares Outstanding (Diluted)	156	152	147	144	143	140
Shares Change (YoY)	5.42%	3.14%	1.88%	1.31%	1.54%	6.97%
EPS (Basic)	-0.33	-0.39	-1.08	-1.56	-1.40	-1.48
EPS (Diluted)	-0.33	-0.39	-1.08	-1.56	-1.40	-1.48
Shares Outstanding	159.7	153.78	147.77	145.08	143.11	141.39
Free Cash Flow	-29.54	-48.95	-98.88	-167.02	-200.29	-254.47
Free Cash Flow Per Share	-0.19	-0.32	-0.67	-1.16	-1.41	-1.81
Gross Margin	75.26%	74.24%	59.72%	55.63%	68.75%	68.06%
Operating Margin	-15.82%	-20.62%	-90.83%	-133.33%	-108.03%	-135.39%
Profit Margin	-16.80%	-21.47%	-89.18%	-132.32%	-108.13%	-134.31%
FCF Margin	-10.00%	-17.67%	-55.25%	-98.09%	-108.09%	-164.87%
EBITDA	-29.79	-39.29	-143.29	-204.8	-179.27	-195.01
EBITDA Margin	-10.08%	-14.19%	-80.07%	-120.28%	-96.74%	-126.35%
EBIT	-46.73	-57.12	-162.55	-227.04	-200.19	-208.97
EBIT Margin	-15.82%	-20.62%	-90.83%	-133.33%	-108.03%	-135.39%

Updated May 5, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q